Welcome to Vioxxhelp.info!

Vioxx (Rofecoxib) is a nonsteroidal anti-inflammatory drug developed by Merck & Co. to treat osteoarthritis , acute pain conditions, and dysmenorrhoea . Rofecoxib was approved as safe and effective by the Food and Drug Administration (FDA) on May 20, 1999 and was subsequently marketed under the brand name Vioxx.

On September 30, 2004, Merck voluntarily withdrew rofecoxib from the market because of concerns about increased risk of heart attack and stroke associated with long-term, high-dosage use. Rofecoxib was one of the most widely used drugs ever to be withdrawn from the market. In the year before withdrawal, Merck had sales revenue of US$2.5 billion from Vioxx.